Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HYALURONIC ACID (RESTYLANE) SYR

Known as: HYALURONIC ACID (RESTYLANE) SYR [VA Product] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Nonsurgical injectable treatments, including hyaluronic acid (HA) fillers, are increasingly used in Asian patients. 
2018
2018
BACKGROUND Adding lidocaine to hyaluronic acid (HA)-based gels appeared to modify their rheological properties, in the view of… Expand
2017
2017
BACKGROUND Hyaluronidase is an enzyme capable of dissolution of hyaluronic acid (HA). There is a lack of evidence-based research… Expand
2015
2015
Abstract Conclusion: The results of the present investigation suggest that modification of HA could improve efficiency and… Expand
2014
2014
Background A variety of hyaluronic acid (HA) fillers demonstrate unique physical characteristics, which affect the quality of the… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
2013
2013
INTRODUCTION In this paper, the authors presented a case of acrylamide poisoning in a middle-aged woman who had underwent… Expand
2010
2010
The aim of this prospective, rater-blind, randomized, intra-individual, 4-week study was to compare the effectiveness and safety… Expand
2010
2010
  • T. Fischer
  • Journal of cosmetic dermatology
  • 2010
  • Corpus ID: 1323984
Background  Juvéderm™ VOLUMA™ (Voluma) is a new injectable, long‐lasting, resorbable hyaluronic acid filler. It restores facial… Expand
2010
2010
The presence of soft tissue fillers in aesthetic surgery has grown exponentially since the introduction of botulinum toxin A into… Expand
Highly Cited
2006
Highly Cited
2006
Background: Several biomaterials are currently available for soft-tissue augmentation. Biocompatibility is an indispensable… Expand